Inhibitor Therapeutics, Inc. (INTI) has 6 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 4, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 4, 2026 filed July 1, 2026 | Black Robe Capital LLC 10% Owner | $0 | 3,200,000 | −14% | No | |
|
|
||||||
| Aug. 4, 2026 filed May 4, 2026 | OSMAN RONALD E Director | $0 | 50,000 | +0% | No | |
|
|
||||||
| Aug. 4, 2026 filed May 4, 2026 | ODONNELL FRANCIS E JR Chief Executive Officer | $0 | 50,000 | +50% | No | |
|
|
||||||
| Aug. 4, 2026 filed May 4, 2026 | Yanez Michelle Director | $0 | 50,000 | +4% | No | |
|
|
||||||
| Aug. 4, 2026 filed May 4, 2026 | SEARS SAMUEL P JR Director | $0 | 50,000 | +4% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free